Franklin Resources Inc Intellia Therapeutics, Inc. Transaction History

Franklin Resources Inc

$334 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 16,405 shares of NTLA stock, worth $187,181. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,405

Previous 16,405 -0.0%

Holding current value

$187,181

Previous $337,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$19.72 - $27.36 $30,329 - $42,079	1,538 Added 10.35%	16,405 $337,000
Q2 2024 Aug 14, 2024	SELL	$20.02 - $27.22 $47,587 - $64,701	-2,377 Reduced 13.78%	14,867 $332,000
Q1 2024 May 13, 2024	BUY	$23.82 - $32.8 $22,104 - $30,438	928 Added 5.69%	17,244 $474,000
Q4 2023 Feb 09, 2024	BUY	$23.16 - $32.34 $54,935 - $76,710	2,372 Added 17.01%	16,316 $497,000
Q3 2023 Nov 13, 2023	SELL	$31.62 - $45.78 $112,788 - $163,297	-3,567 Reduced 20.37%	13,944 $440,000
Q2 2023 Aug 11, 2023	BUY	$34.58 - $46.03 $264,260 - $351,761	7,642 Added 77.43%	17,511 $714,000
Q1 2023 May 12, 2023	SELL	$33.3 - $44.82 $30,669 - $41,279	-921 Reduced 8.54%	9,869 $367,000
Q4 2022 Feb 10, 2023	BUY	$33.21 - $62.69 $9,896 - $18,681	298 Added 2.84%	10,790 $376,000
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $24.6 Million - $32.7 Million	-456,181 Reduced 97.75%	10,492 $588,000
Q2 2022 Aug 11, 2022	SELL	$38.49 - $76.21 $19.2 Million - $38.1 Million	-499,965 Reduced 51.72%	466,673 $24.2 Million
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $9.49 Million - $19.4 Million	-162,943 Reduced 14.43%	966,638 $70.2 Million
Q4 2021 Feb 11, 2022	BUY	$100.76 - $138.36 $15.1 Million - $20.8 Million	150,131 Added 15.33%	1,129,581 $134 Million
Q3 2021 Nov 12, 2021	BUY	$132.37 - $176.78 $78 Million - $104 Million	589,302 Added 151.05%	979,450 $131 Million
Q2 2021 Aug 13, 2021	BUY	$60.88 - $161.91 $22.9 Million - $61 Million	376,767 Added 2815.69%	390,148 $63.2 Million
Q1 2021 May 13, 2021	BUY	$46.59 - $83.68 $233,136 - $418,734	5,004 Added 59.73%	13,381 $1.07 Million
Q4 2020 Feb 10, 2021	BUY	$18.83 - $63.53 $157,738 - $532,190	8,377 New	8,377 $455,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $867M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Intellia Therapeutics, Inc. Transaction History